{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:05:52Z","timestamp":1783926352574,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA21145"],"award-info":[{"award-number":["CA21145"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0208"],"award-info":[{"award-number":["P1-0208"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["J3-50123"],"award-info":[{"award-number":["J3-50123"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0017"],"award-info":[{"award-number":["P1-0017"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["39013"],"award-info":[{"award-number":["39013"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.118993","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T23:32:05Z","timestamp":1779492725000},"page":"118993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antibacterial and antibiofilm activities of novel bacterial topoisomerase inhibitors against Staphylococcus aureus and other clinically relevant pathogens"],"prefix":"10.1016","volume":"316","author":[{"given":"Ma\u0161a","family":"Zorman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Minovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017diva","family":"Zajec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Anderluh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majda","family":"Golob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Radakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Atanaskovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Senerovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hrast-Rambaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118993_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118993_bib2","series-title":"Global Antibiotic Resistance Surveillance Report 2025 WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS)","year":"2025"},{"key":"10.1016\/j.ejmech.2026.118993_bib3","unstructured":"WHO publishes list of bacteria for which new antibiotics are urgently needed, (n.d.). https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (accessed August 21, 2023)."},{"key":"10.1016\/j.ejmech.2026.118993_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1086\/666640","article-title":"Increasing burden of Methicillin-resistant Staphylococcus aureus hospitalizations at US academic medical centers, 2003\u20132008","volume":"33","author":"David","year":"2012","journal-title":"Infect. Control Hosp. Epidemiol. : The Official Journal of the Society of Hospital Epidemiologists of America"},{"key":"10.1016\/j.ejmech.2026.118993_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijantimicag.2006.09.001","article-title":"Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control","volume":"28","author":"Gould","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2026.118993_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20405-8","article-title":"Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds","volume":"12","author":"Kolari\u010d","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118993_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106087","article-title":"Diminishing hERG inhibitory activity of aminopiperidine-naphthyridine linked NBTI antibacterials by structural and physicochemical optimizations","volume":"128","author":"Kokot","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118993_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115160","article-title":"Amide containing NBTI antibacterials with reduced hERG inhibition, retained antimicrobial activity against gram-positive bacteria and in vivo efficacy","volume":"250","author":"Kokot","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118993_bib9","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/acsmedchemlett.1c00345","article-title":"Structurally optimized potent dual-targeting NBTI antibacterials with an enhanced bifurcated Halogen-Bonding propensity","volume":"12","author":"Kokot","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118993_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbrc.2013.11.012","article-title":"Biofilm vs. planktonic bacterial mode of growth: which do human macrophages prefer?","volume":"441","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118993_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s44259-024-00046-3","article-title":"Mechanisms of antimicrobial resistance in biofilms","volume":"2","author":"Liu","year":"2024","journal-title":"Npj Antimicrobials and Resistance"},{"key":"10.1016\/j.ejmech.2026.118993_bib12","unstructured":"The role of bacterial biofilms in antimicrobial resistance, (n.d.). https:\/\/asm.org\/articles\/2023\/march\/the-role-of-bacterial-biofilms-in-antimicrobial-re (accessed November 20, 2025)."},{"key":"10.1016\/j.ejmech.2026.118993_bib13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2014.10.024","article-title":"ESCMID\u2217 guideline for the diagnosis and treatment of biofilm infections 2014","volume":"21","author":"H\u00f8iby","year":"2015","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.ejmech.2026.118993_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/antibiotics12010012","article-title":"A review of biofilm formation of Staphylococcus aureus and its regulation mechanism","volume":"12","author":"Peng","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.118993_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2023.100175","article-title":"Staphylococcus aureus biofilm: formulation, regulatory, and emerging natural products-derived therapeutics","volume":"7","author":"Wu","year":"2024","journal-title":"Biofilm"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118993_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-26971-5","article-title":"Implant-associated biofilms of Staphylococcus aureus and Enterococcus faecalis clinical isolates on expanded polytetrafluoroethylene suture in Galleria mellonella model","volume":"15","author":"Mirza","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118993_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00342","article-title":"A systematic evaluation of the two-component systems network reveals that ArlRS is a key regulator of catheter colonization by Staphylococcus aureus","volume":"9","author":"Burgui","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118993_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106866","article-title":"Mixed species biofilm: structure, challenge and its intricate involvement in hospital associated infections","volume":"195","author":"Biswas","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejmech.2026.118993_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1435720","article-title":"Antibiotics with antibiofilm activity \u2013 rifampicin and beyond","volume":"15","author":"Ferreira","year":"2024","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118993_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41579-023-00905-2","article-title":"Drug delivery strategies for antibiofilm therapy","volume":"21","author":"Choi","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118993_bib21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.4155\/fmc-2016-0042","article-title":"Targeting bacterial topoisomerases: how to counter mechanisms of resistance","volume":"8","author":"Tse-Dinh","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118993_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.esp-0010-2014","article-title":"DNA topoisomerases","volume":"6","author":"Bush","year":"2015","journal-title":"EcoSal Plus"},{"key":"10.1016\/j.ejmech.2026.118993_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.47.3.869-877.2003","article-title":"Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin","volume":"47","author":"Schmutz","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118993_bib24","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/jac\/dkr247","article-title":"Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics","volume":"66","author":"Alt","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.118993_bib25","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.3390\/molecules25235662","article-title":"Quinolones: mechanism, lethality and their contributions to antibiotic resistance","volume":"25","author":"Bush","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118993_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.118993_bib27","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118993_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2021.100017","article-title":"Novel bacterial topoisomerase inhibitors (NBTIs) \u2013 a comprehensive review","volume":"3","author":"Desai","year":"2021","journal-title":"European Journal of Medicinal Chemistry Reports"},{"key":"10.1016\/j.ejmech.2026.118993_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02100-16","article-title":"Novel bacterial topoisomerase inhibitors with potent broad-spectrum activity against drug-resistant bacteria","volume":"61","author":"Charrier","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118993_bib30","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/AAC.00496-08","article-title":"Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases","volume":"52","author":"Black","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118993_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejmech.2018.04.059","article-title":"New developments in non-quinolone-based antibiotics for the inhibiton of bacterial gyrase and topoisomerase IV","volume":"152","author":"Badshah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118993_bib32","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1128\/AAC.00571-15","article-title":"Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureus","volume":"59","author":"Lahiri","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118993_bib33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118993_bib34","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1021\/acs.jmedchem.2c00039","article-title":"The structural features of novel bacterial topoisomerase inhibitors that define their activity on topoisomerase IV","volume":"65","author":"Kokot","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118993_bib35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(23)02697-1","article-title":"Gepotidacin, a new first-in-class antibiotic for treating uncomplicated urinary tract infection","volume":"403","author":"Ali","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118993_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01221-18","article-title":"Microbiological analysis from a phase 2 randomized study in adults evaluating single oral doses of gepotidacin in the treatment of uncomplicated urogenital gonorrhea caused by Neisseria gonorrhoeae","volume":"62","author":"Scangarella-Oman","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118993_bib37","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4155\/fmc-2018-0272","article-title":"Novel bacterial topoisomerase inhibitors: challenges and perspectives in reducing hERG toxicity","volume":"10","author":"Kolari\u010d","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118993_bib38","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/acsinfecdis.8b00375","article-title":"1,3-Dioxane-Linked bacterial topoisomerase inhibitors with enhanced antibacterial activity and reduced hERG inhibition","volume":"5","author":"Li","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118993_bib39","series-title":"SUBSTITUTED (AZA) -1-METHYL-1H-QUIN0LIN-2-0NES AS ANTIBACTERIALS","author":"Jones","year":"2010"},{"key":"10.1016\/j.ejmech.2026.118993_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/infdis\/135.2.217","article-title":"Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time","volume":"135","author":"MacDonald","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118993_bib42","article-title":"Hp1404, a new antimicrobial peptide from the scorpion Heterometrus petersii","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118993_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113858","article-title":"Combatting AMR: a molecular approach to the discovery of potent and non-toxic rhenium complexes active against C. albicans-MRSA co-infection","volume":"226","author":"Sovari","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118993_bib44","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.bmcl.2018.06.003","article-title":"Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety","volume":"28","author":"Li","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118993_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-99766-3","article-title":"hERG toxicity prediction in early drug discovery using extreme gradient boosting and isometric stratified ensemble mapping","volume":"15","author":"Falc\u00f3n-Cano","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118993_bib46","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1021\/acs.jcim.1c00744","article-title":"Structure-based prediction of hERG-Related cardiotoxicity: a benchmark study","volume":"61","author":"Creanza","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118993_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118993_bib48","series-title":"MICROBE 2016","article-title":"Gepotidacin (GSK2140944) in vitro activity against Neisseria gonorrhoeae (MIC\/MBC, kill kinetics, checkerboard, PAE\/SME tests)","author":"Farrel","year":"2016"},{"key":"10.1016\/j.ejmech.2026.118993_bib49","unstructured":"BLUJEPA. Prescribing Information., (n.d.). www.fda.gov\/medwatch. (accessed April 29, 2026)."},{"key":"10.1016\/j.ejmech.2026.118993_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clinthera.2026.01.009","article-title":"BLUJEPA (gepotidacin)","volume":"48","author":"Beninger","year":"2026","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejmech.2026.118993_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2013.00020","article-title":"Concentration-dependent activity of antibiotics in natural environments","volume":"4","author":"Bernier","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118993_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1194952","article-title":"Sub-MIC antibiotics influence the microbiome, resistome and structure of riverine biofilm communities","volume":"14","author":"Flores-Vargas","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118993_bib53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tim.2024.12.011","article-title":"Moonlighting antibiotics: the extra job of modulating biofilm formation","volume":"33","author":"Cordisco","year":"2025","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2026.118993_bib54","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1186\/s12879-024-09790-3","article-title":"Antimicrobial Sub-MIC induces Staphylococcus aureus biofilm formation without affecting the bacterial count","volume":"24","author":"Elawady","year":"2024","journal-title":"BMC Infect. Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:16:03Z","timestamp":1783923363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S0223523426004381"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118993","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial and antibiofilm activities of novel bacterial topoisomerase inhibitors against Staphylococcus aureus and other clinically relevant pathogens","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118993"}}